Is it worthwhile to screen patients with type 2 diabetes mellitus for subclinical Cushing's syndrome?

Variable prevalence of subclinical Cushing's syndrome (SCS) has been reported in patients with type 2 diabetes mellitus (T2DM), making the need for screening in this population uncertain. It is unknown if this variability is solely due to study-related methodological differences or a reflection...

Descripción completa

Detalles Bibliográficos
Autores principales: Budyal, Sweta, Jadhav, Swati Sachin, Kasaliwal, Rajeev, Patt, Hiren, Khare, Shruti, Shivane, Vyankatesh, Lila, Anurag R, Bandgar, Tushar, Shah, Nalini S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621608/
https://www.ncbi.nlm.nih.gov/pubmed/26420669
http://dx.doi.org/10.1530/EC-15-0078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621608/
https://www.ncbi.nlm.nih.gov/pubmed/26420669
http://dx.doi.org/10.1530/EC-15-0078

Ejemplares similares